About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Phoenix | 174 Studies

Clinical Trials HypertensionPhoenix

Hypertension Clinical Trials in Phoenix

Find 174 clinical trials for hypertension near Phoenix, Arizona. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-174 of 174 trials

CompletedFREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)This study was an international, multicenter, randomized (2:1 active:placebo), double-blind, placebo-controlled study in subjects with PAH who were NOT currently receiving…NCT00325403·Birmingham, Alabama and 76 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionThe purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with amlodipine in treating individuals with essential…NCT00591266·Mesa, Arizona and 49 others

CompletedStudy of Ambrisentan in Participants With Pulmonary HypertensionThe primary objective of this study is to monitor the long-term safety of ambrisentan in adult participants with pulmonary hypertension.NCT00777920·Birmingham, Alabama and 45 others

CompletedOPsumit USers RegistryProspective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics…NCT02126943·Mobile, Alabama and 145 others

Active not recruitingA Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionThe primary objective of this study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right…NCT05203510·Phoenix, Arizona and 27 others

CompletedPulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension ProgramKnowledge Translation Program for the guidelines and evidence-based management of PAH patientsNCT01389206·Birmingham, Alabama and 75 others

CompletedHabitual Hypertension Medication Adherence in ArizonaThis research will implement a novel habit formation intervention among people living with hypertension and an indication of medication non-adherence to help maintain high…NCT05672797·Phoenix, Arizona

CompletedGB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)The primary objective for this trial is to determine the effect of GB002 (seralutinib) on improving pulmonary hemodynamics in subjects with World Health Organization (WHO) Group 1…NCT04456998·Phoenix, Arizona and 62 others

CompletedACT-293987 in Pulmonary Arterial HypertensionLong-term, single-arm, multicenter, open-label extension, Phase 3 study, to evaluate the safety and tolerability of ACT-293987 in patients with PAH who participated in the…NCT01112306·Mobile, Alabama and 156 others

Enrolling by invitationGlobal Utilization And Registry Database for Improved preservAtion of doNor LUNGsThe objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported…NCT04930289·Phoenix, Arizona and 14 others

CompletedSafety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary DiseaseThis study is being conducted to see if PRX-08066 can lower pulmonary artery pressures in patients with pulmonary hypertension associated with chronic obstructive pulmonary…NCT00345774·Anniston, Alabama and 18 others

TerminatedCOREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And MicroalbuminuriaThis study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood…NCT00123903·Birmingham, Alabama and 93 others

TerminatedOral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionThis was a multicenter, randomized (1:1; oral treprostinil to placebo), double-blind, placebo-controlled study in subjects with World Health Organization (WHO) Group 2 pulmonary…NCT03037580·Birmingham, Alabama and 81 others

CompletedStudy of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)To evaluate the change from baseline in pulmonary vascular resistance (PVR), and other hemodynamic parameters, following the addition of ambrisentan to background…NCT00617305·Mobile, Alabama and 29 others

PreviousPage 9 of 9

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia